Lv5
890 积分 2023-12-09 加入
The real-world safety profile of pemetrexed and platinum with or without pembrolizumab: insights from a comparative analysis of FAERS database
9天前
已完结
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database
11天前
已完结
A Drug Similarity-Based Bayesian Method for Early Adverse Drug Event Detection
12天前
已完结
A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
12天前
已关闭
Re-assessing the risk-benefit profile of Thiazolidinediones: Cardiovascular Risks and Stroke Prevention Through Real-World Data
14天前
已关闭
Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis
22天前
已完结
Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database
26天前
已完结
Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study
1个月前
已关闭
Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system
1个月前
已完结
Eosinophil‐induced adverse events induced by treatment with programmed cell death 1/ligand 1 inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
1个月前
已完结
皖公网安备34019202002308
